New objective measure – the “ARMSS rate” – provides early warning of future disability

Researchers at the Karolinska Institutet, Stockholm, Sweden, have developed an objective measure based on the Age Related Multiple Sclerosis Severity (ARMSS) score that may help predict patients’ disease course early during treatment.